Improving the use of research evidence in guideline development: 10. Integrating values and consumer involvement
Tóm tắt
Từ khóa
Tài liệu tham khảo
Torrance GW Feeny, D:Utilities and quality-adjusted life years. Int J Tech Ass Health Care. 1989, 5(4): 559-575.
Giacomini MK Cook DJ, Streiner DL, Anand SS:Using practice guidelines to allocate medical technologies: an ethics framework. Int J Technol Health Care. 2000, 16: 987-1002. 10.1017/S026646230010306X.
Hofmann B: Toward a procedure for integrating moral issues in health technology assessment. Int J Technol Health Care. 2005, 21: 312-318.
Bennett KJ Torrance, GW: Measuring health state preferences and utilities: rating scale, time trade-off, and standard gamble techniques. Quality of life and pharmacoeconomics in clinical trials. Edited by: Spilker B. 1996, Philadelphia , Lippincott-Raven, 259-second
Ryan M, Scott DA, Reeves C, Bate A, van Teijlingen ER, Russell EM, Napper M, Robb CM: Eliciting public preferences for healthcare: a systematic review of techniques. Health Technol Assess. 2001, 5 (5): 1-186.
Froberg DG, Kane RL: Methodology for measuring health-state preferences--I: Measurement strategies. Journal of Clinical Epidemiology. 1989, 42 (4): 345-354. 10.1016/0895-4356(89)90039-5.
Brazier J Usherwood T, Harper R, Thomas K: Deriving a preference-based single index from the UK SF-36 Health Survey. J Clin Epidemiol. 1998, 51: 1115-1128. 10.1016/S0895-4356(98)00103-6.
Torrance GW Furlong W, Feeny DH, Boyle M: Multiattribute preferences functions: Health Utilities Index. Pharmacoeconomics. 1995, 6: 503-520.
Kaplan RM Bush JW, Berry CC: Health Status: Types of Validity and the Index of Well-being. Health Services Res. 1976, 11: 478-507.
EuroQol-Group: EuroQol - a new facility for the measurement of health-related quality of life. Health Pol. 1990, 16: 199-208. 10.1016/0168-8510(90)90421-9.
Guyatt G Gutterman D, Baumann M, Addrizzo-Harris D, Hylek E, Phillips B, Raskob G, Lewis S, Schünemann H.: Grading strength of recommendations and quality of evidence in clinical guidelines. Chest. 2006, 129: 174-181. 10.1378/chest.129.1.174.
Buller HRA G. Hull, RD. Hyers, TM. Prins, MH. Raskob GE.: Antithrombotic Therapy for Venous Thromboembolic Disease. CHEST. 2004, 126: 401S– 428S-10.1378/chest.126.3_suppl.401S.
Devereaux PJ, Anderson DR, Gardner MJ, Putnam W, Flowerdew GJ, Brownell BF, Nagpal S, Cox JL: Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational study. Bmj. 2001, 323 (7323): 1218-1222. 10.1136/bmj.323.7323.1218.
Pritchard RS, Anthony SP: Chemotherapy plus Radiotherapy Compared with Radiotherapy Alone in the Treatment of Locally Advanced, Unresectable, Non-Small-Cell Lung Cancer: A Meta-Analysis. Ann Intern Med. 1996, 125 (9): 723-729.
Robinson LA, Wagner H, Ruckdeschel JC: Treatment of Stage IIIA Non-small Cell Lung Cancer. Chest. 2003, 123 (90010): 202S-220. 10.1378/chest.123.1_suppl.202S.
AGREE, Collaboration: Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project. Qual Saf Health Care. 2003, 12 (1): 18-23. 10.1136/qhc.12.1.18.
Hayward RS WMC Tunis SR, Bass EB, Rubin HR, Haynes RB: More informative abstracts of articles describing clinical practice guidelines. Ann Intern Med. 1993, 118: 731-737.
Rawlins MD, Culyer AJ: National Institute for Clinical Excellence and its value judgments. Bmj. 2004, 329 (7459): 224-227. 10.1136/bmj.329.7459.224.
Fretheim A Schünemann HJ, Oxman AD: Improving the Use of Research Evidence in Guideline Development: 3. Group composition. Health Res Policy Syst. 2006
Oxman AD Schünemann HJ, Fretheim A.: Improving the Use of Research Evidence in Guideline Development: 12. Incorporating considerations of equity. Health Res Policy Syst. 2006
Schünemann HJ Fretheim A, Oxman, AD:Improving the Use of Research Evidence in Guideline Development: 6. Determining which outcomes are important. Health Res Policy Syst. 2006
Global Programme on Evidence for Health Policy. Guidelines for WHO Guidelines. EIP/GPE/EQC/2003.1. 2003, Geneva , World Health Organization
The 2000 consensus conference on clinical practice guidelines. Toronto. Health Policy Forum; 2000 Nov 2.
Moynihan R Paulsen, E, Lavis, J, Oxman, AD: A survey of producers of clinical practice guidelines and health technology assessments. 2005
Burgers JS, Grol R, Klazinga NS, Makela M, Zaat J: Towards evidence-based clinical practice: an international survey of 18 clinical guideline programs. Int J Qual Health Care. 2003, 15 (1): 31-45. 10.1093/intqhc/15.1.31.
Kelson MC: The NICE Patient Involvement Unit. Evidence-Based Healthcare & Public Health. 2005, 9: 304–307-
Royle J, Oliver S: Consumer involvement in the health technology assessment program. Int J Technol Assess Health Care. 2004, 20 (4): 493-497.
Oliver S: The progress of lay involvement in the NHS Research and Development Programme. J Eval Clin Pract. 1996, 2 (4): 273-280.
Oliver S, Clarke-Jones L, Rees R, Milne R, Buchanan P, Gabbay J, Gyte G, Oakley A, Stein K: Involving consumers in research and development agenda setting for the NHS: developing an evidence-based approach. Health Technol Assess. 2004, 8 (15): 1-148, III-IV.
Oliver S, Milne R, Bradburn J, Buchanan P, Kerridge L, Walley T, Gabbay J: Involving consumers in a needs-led research programme: a pilot project. Health Expect. 2001, 4 (1): 18-28. 10.1046/j.1369-6513.2001.00113.x.
Brainin M, Barnes M, Baron JC, Gilhus NE, Hughes R, Selmaj K, Waldemar G: Guidance for the preparation of neurological management guidelines by EFNS scientific task forces - revised recommendations 2004. European Journal of Neurology. 2004, 11 (9): 577-581. 10.1111/j.1468-1331.2004.00867.x.
Kelson MC: Consumer collaboration, patient-defined outcomes and the preparation of Cochrane Reviews. Health Expectations. 1999, 2 (2): 129-135. 10.1046/j.1369-6513.1999.00042.x.
CCNET: Consumers in Cochrane. [ http://www.cochrane.org/consumers/homepage.htm ]
Oxman AD Fretheim A, Schünemann HJ: Improving the Use of Research Evidence in Guideline Development: Introduction. Health Res Policy Syst. 2006
Agency for Healthcare Research and Quality. [ http://www.guidelines.gov ]
Guidelines International Network. [ http://www.g-i-n.net ]
Dolders MGT, Zeegers MPA, Groot W, Ament A: A Meta-analysis demonstrates no significant differences between Patient and Population Preferences. Journal of Clinical Epidemiology.
Nilsen ES: Interventions for promoting consumer involvement in developing healthcare policy and research, clinical practice guidelines and patient information material. Cochrane Library. submitted
Crawford MJ, Rutter D, Manley C, Weaver T, Bhui K, Fulop N, Tyrer P: Systematic review of involving patients in the planning and development of health care. Bmj. 2002, 325 (7375): 1263-10.1136/bmj.325.7375.1263.
Morimoto T, Fukui T: Utilities measured by rating scale, time trade-off, and standard gamble: review and reference for health care professionals. J Epidemiol. 2002, 12 (2): 160-178.
Owens DK: Spine update. Patient preferences and the development of practice guidelines. Spine. 1998, 23 (9): 1073-1079. 10.1097/00007632-199805010-00023.
Slomka J, Hoffman-Hogg L, Mion LC, Bair N, Bobek MB, Arroliga AC: Influence of clinicians' values and perceptions on use of clinical practice guidelines for sedation and neuromuscular blockade in patients receiving mechanical ventilation. Am J Crit Care. 2000, 9 (6): 412-418.
Guyatt G: Moving from Evidence to Action. Incorporating patient values. Users' Guide to the Medical Literature: A Manual for Evidence-Based Clinical Practice. Edited by: Guyatt G RD. 2002, Chicago , AMA Press, 567-582.
van Wersch A, Eccles M: Involvement of consumers in the development of evidence based clinical guidelines: practical experiences from the North of England evidence based guideline development programme. Qual Saf Health Care. 2001, 10 (1): 10-16. 10.1136/qhc.10.1.10.
Telford R, Boote JD, Cooper CL: What does it mean to involve consumers successfully in NHS research? A consensus study. Health Expect. 2004, 7 (3): 209-220. 10.1111/j.1369-7625.2004.00278.x.
Schünemann HJ, Fretheim A, Oxman AD: Templates, adaptation and the role of international guidelines. (submitted as part of this series)
Schünemann HJ: Improving the Use of Research Evidence in Guideline Development: 13. Adaptation, applicability and transferability. Health Res Policy Syst. 2006